The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.
The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.
Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.
Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.
“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”
The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.
Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:
Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.
The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.
Regenerative Therapies Market – Insights Regenerative therapies deliver specific types of cells or cell products to diseased tissues or organs to restore tissue and organ function. Materials used in regener... Read more
Life Science Products Market – Insights Life science, also referred as biology, is the study of life and living things. It includes anatomy, animal biology, bacteriology, biochemistry, cell biology, ecology... Read more
Glycobiology Market – Insights The term glycobiology is a branch of biology that deals with study of structure, function, and biosynthesis of saccharides (carbohydrates and carbohydrates containing molecule... Read more
Viral Vector and Plasmid DNA Testing Services Market – Market Insights Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials i... Read more
GMP Cell Banking Services Market – Insights Cell banking involves storing of cells of specific genome for the purpose of future use in a product or medicinal needs. Mammalian cells, microbial cells, insect ... Read more
DNA and RNA Sample Preparation Market – Insights DNA and RNA sample preparation provides accessibility to nucleic acids in a natural form and removes unwanted contaminants. DNA and RNA sample preparation pr... Read more
Inactivated Polio and Rabies Vaccines Market – Insights A vaccine consist of a biological preparation, which upon injection stimulates the immune system to secrete antibodies against the age... Read more
Proteinase K Market – Insights Proteinase K is a serine protease produced by the fungus Tritirachium album Limber. It is used as enzyme or reagent in different chemical reactions. It digests ... Read more
Companion Animal Vaccines Market – Insights There are two types of small companion animal vaccine available: ‘infectious’ or ‘non-infectious’ in nature. Infectious vaccines used in d... Read more
Europe Platelet-rich Plasma Market – Insights Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s... Read more
Definition of Market/Industry: Biophotonics is a branch of science that deals with producing and using the photons of light to create an image, identify, and engineer biological materials. Biophotonics is a combina... Read more
Assistive Reproductive Technology Market - Insights Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and ... Read more
Cervical Cancer Vaccines Market – Insights Cervical cancer is currently the leading cause of cancer mortality among women worldwide. According to World Health Organization 2018, around 90% of deaths fro... Read more
Stem Cell Therapy Market – Market Insights Stem cells are derived from the human cells. Stem cell therapy is also known as regenerative medicine. Regenerative medicine refers to a group of biomedical ap... Read more
Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Insights Nucleic acid sequence-based amplification is a type of method in molecular biology, which is used to amplify RNA sequences. Isother... Read more
Bacteriophage Therapy Market – Market Insights Bacteriophages have been researched as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bact... Read more
Global Conjugate Vaccine Market Insights Increasing collaborations among key players to develop and introduce vaccines for pneumococcal and meningococcal diseases in the market and ongoing clinical trial stud... Read more
Lifescience Reagent Market Insights Increasing prevalence of infectious disease, which requires early diagnosis is creating the opportunity for the biotechnology industry players to produce effective reagents... Read more